#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Candida infection Acquired ATTR amyloidosis Primary hyperoxaluria SAPHO syndrome Peripheral T-cell lymphoma unspecified Loeys-Dietz syndrome Immune-mediated enterocolitis B-cell type acute leukaemia VEXAS syndrome Phenylketonuria Fibrosarcoma Vernal keratoconjunctivitis Chronic graft versus host disease in skin Acute leukaemia Gaucher's disease type I More trials…

    Learn about Rare Diseases

    Retinitis pigmentosa – Diagnostics Cytokine release syndrome – Treatment Ewing’s sarcoma recurrent – Treatment SAPHO syndrome – Diagnostics Andersen-Tawil syndrome – Basic Information Haemophilia A without inhibitors – Diagnostics CADASIL – Life with Disease Langerhans’ cell histiocytosis Osteosarcoma – Diagnostics Glycogen storage disease type I – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rosuvastatin Calcium Piromelatine GOVORESTAT Prucalopride ALN-4324 Fosphenytoin Sodium Rosuvastatin Zinc Erythromycin Lactobionate Prednisolone Sodium Phosphate Sxr1096 Landiolol Hydrochloride Aliskiren Gsk3965193B SP16 Ticagrelor Montelukast Basiliximab Asparaginase Myrrh Navitoclax More therapies…

    Learn about Your Condition

    Lung cancer metastatic H1N1 influenza Cushing's syndrome Hypophosphatasia Thalassaemia alpha Urinary tract infection Renal cell carcinoma Corticobasal degeneration Glomerulonephritis membranous Hairy cell leukaemia recurrent Mumps Rubella Precocious puberty Myeloid leukaemia Rectal neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effectiveness of Denosumab with Chemotherapy (Cisplatin, Methotrexate, Doxorubicin) for Patients with Metastatic Osteosarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteosarcoma metastatic
    Investigated Drugs:
    • Denosumab
    • Cisplatin
    • Doxorubicin Hydrochloride
    Italy

  • Study on Deferoxamine for Patients with Aneurysmal Subarachnoid Hemorrhage

    Recruiting

    1 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Deferoxamine Mesilate
    The Netherlands

  • Study on the Effects of Losartan Potassium in Patients with Mild to Moderate Aortic Stenosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Aortic stenosis
    Investigated Drugs:
    • Losartan Potassium
    • Placebo
    Denmark

  • Study on [68Ga]Ga-FAPI-46 and Fludeoxyglucose (18F) PET/CT Imaging for Evaluating Treatment Response in Patients with Advanced Malignant Melanoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Fludeoxyglucose (18F)
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    Denmark

  • Study Comparing Serratus Plane Block, Capsaicin, and Botulinum Toxin Type A for Chronic Pain in Post-Mastectomy Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuralgia
    • Post breast therapy pain syndrome
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • MORPHINE
    • Naloxone Hydrochloride
    France

  • Study of Pembrolizumab and Lenvatinib for Patients with Advanced Vulvar Cancer Not Suitable for Surgery or Radiotherapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Lenvatinib
    • Pembrolizumab
    Germany
Previous Page
1 … 274 275 276 277 278 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!